Dark

LENZ
LENZ Therapeutics, Inc. Common Stock
stock NASDAQ

Market Open

Aug 11, 2026 1:22:08 PM EDT

5.32USD-0.653%(-0.04)205,763

5.31Bid 5.34Ask 0.03Spread

Pre-market

Aug 11, 2026 9:22:30 AM EDT

5.37USD+0.192%(+0.01)4,629

After-hours

Aug 7, 2026 4:00:30 PM EDT

5.36USD-0.093%(0.00)0

OverviewOptionsHistoricalExchangesShortsTrends

open chart

Market Cap

166.96M

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Next Earnings

Aug 11, 2026 (today)

Last Split

Mar 22, 20241for7reverse

LENZ Stats

Avg. Vol. 10 Day

698,629

Avg. Vol. 30 Day

974,238

Market Cap

166,959,013

Shares Out.

31,354,394

On/Off Exchange

57%/43%

6 Month Beta

1.43

1 Year Beta

1.35

2 Year Beta

1.55

3 Year Beta

1.54

52 Week Low

4.68

52 Week High

50.40

SMA50

5.88

SMA200

13.66

1 Week

+5.44%

1 Month

-4.74%

3 Month

-46.70%

6 Month

-60.59%

1 Year

-86.27%

2 Year

-77.03%

Profile

graphite bio is a next-generation gene editing company focused on the development of first-in-class therapies for patients suffering from life-threatening genetic diseases. the company's platform harnesses the natural cellular process of homology directed repair (hdr) and targeted dna integration to precisely repair genetic defects at their source. graphite bio is leveraging its differentiated platform to advance a portfolio of transformative genetic treatments with potential for saving and dramatically improving patients' lives

LENZ Stock Summary

LENZ Therapeutics, Inc. Common Stock (NASDAQ:LENZ) stock price today is $5.32, and today's volume is 205,763. LENZ is down -0.653% today. The 30 day average volume is 974,238. LENZ market cap is 166.96M with 31,354,394 shares outstanding.

.dark-mode .GPTLcz{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .GPTLcz{ color: #333333; background-color: white; border: 2px solid #333333; }LENZLENZ Therapeutics, Inc. Common Stockstock NASDAQ

LENZ Stock Summary

LENZ
LENZ Therapeutics, Inc. Common Stock
stock NASDAQ